Oramed pharmaceuticals inc

Major-Pharmaceuticals

ORMP


142 West 57th Street
New York , NY 10019

Executive/
Director

Price

  • Last Close
  • $ 2.52
    $ +0.12 4.79 %
    Dec 9, 2024
  • 52-Week High/Low
  • $3.58 - $1.71
  • YTD
  • 8.9%

  • Trading Volume
  • 3,417
  • Market Cap Full
  • $ 101.7M
  • Shares Outstanding
  • 40.3M
    Nov 9, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 39.7% -22.1% 0.5% -27.7% 21.3% -5% 139.6% -37.8% -81.9% 26.4%
Q2 -10.8% 25.2% 26.3% 16.6% -0.7% 4% 31.7% -48.4% 64.2% -
Q3 -3.7% -13% 27.8% -31.5% -10.8% 8% 67% 41.5% -27.1% -
Q4 56.3% -15.7% -11.2% -38.1% 65.1% 62.5% -36.1% 85.7% -10.1% -
J F M A M J J A S O N D
2024 29.7% 9.9% -11.3% -3.1% - - - - - - - -
2023 -83.5% 5.5% 3.8% 4.1% 78% -11.4% -5.3% -3.2% -20.4% -29.9% 21.3% 4.1%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    -70%88%-28%47%-67%77%-20%237%-16%-81%9%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.15 0.14 0.24 -0.2 -0.21 -0.21 -0.17 -0.27 -0.08
Q2 0.15 - 0.15 -0.3 -0.23 -0.1 -0.17 -0.27 -0.03
Q3 0.19 0.37 0.20 -0.18 -0.13 -0.1 -0.67 -0.18 -0.08
Q4 0.21 0.20 0.18 -0.25 -0.15 -0.23 0.22 -0.22 -
A 0.7 0.7 0.8 -0.9 -0.7 -0.6 -0.8 0.9 -0.19

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar 14.4 17.4 17.7 26.7 38.6 39.8
Jun 14.4 17.4 23.1 30.2 38.6 40
Sep 17.4 17.4 23.5 32.5 38.8 40.3
Dec 17.4 17.4 23.7 38.1 39.1 40.3
Annual

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.8 - 0.1 0.8 3
Total Asset Turnover - - - 0.1 0.1
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 10.3 - 12 - 15
Equity multiplier - 0.2 0.3 0.1 0.1